PMA device
Focus Night and Day (Lotrafilcon A) Soft Contact Lenses
Alcon Laboratories, Inc. · Lenses, Soft Contact, Extended Wear (LPM, Class III) · First FDA decision Oct 11, 2001, newest Jul 5, 2002Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
10
Naming "Focus Night"
MAUDE reports
2
Brand "Focus Night", since 2015
PubMed studies
48
Mentioning "Focus Night"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Focus Night and Day (Lotrafilcon A) Soft Contact Lenses
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- FOCUS NIGHT AND DAY (LOTRAFILCON A) SOFT CONTACT LENSESPMA supplement
P010019-S001 · Decided Jul 5, 2002 · 91 days after receipt · Normal 180 Day Track
Device type: Lenses, soft contact, extended wear (LPM) · Ophthalmology
P010019 · Decided Oct 11, 2001 · 204 days after receipt
Device type: Lenses, soft contact, extended wear (LPM) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hydrophilic Contact LensesNational determinationOn the books80.4Updated Jun 11, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Focus Night", any status and sponsor, newest update first.
- Prospective Evaluation of New Metrics to Assess Cardiovascular Remodeling in Obstructive Sleep ApneaRecruiting
University Hospital, AntwerpAcademic, hospital or other
NCT07427589 · 270 participants (planned) · Start Jun 10, 2026 · Primary completion Dec 2029
Device: Continuous positive airway pressure; Mandibular advancement device and 1 more · For: Obstructive Sleep Apnea; Cardiovascular (CV) Risk
Sites: Antwerp, Belgium
University of Texas at AustinAcademic, hospital or other
NCT07190287 · 52 participants · Start Jul 15, 2025 · Primary completion Oct 3, 2025
Device: NEUSleeP system (FUS-EEG wearable device); BrainSonix Pulsar 1002 · For: Sleep Disturbance; Stress, Psychological; REM Sleep Measurement
Sites: Austin, Texas
Queen Mary University of LondonAcademic, hospital or other
NCT06174948 · 70 participants (planned) · Start Mar 25, 2024 · Primary completion Mar 31, 2025
Device: CUE1 non-invasive device; CUE1+ device active vs sham CUE1+ device · For: Parkinson's Disease and Parkinsonism; Progressive Supranuclear Palsy; Different Types of Tremor Including Essential Tremor and 5 more
Sites: London, United Kingdom
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Focus Night", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code LPM
1,788 reports: 19 malfunction, 1,759 injury, 0 death
Newest reports for this brand
- FOCUS NIGHT & DAYInjury
9681121-2023-00008 · Received Jun 7, 2023
Device type: Lenses, Soft Contact, Extended Wear (LPM)
Device problem as coded: Microbial Contamination of Device
Patient problem as coded: Conjunctivitis; Corneal Scar; Corneal Ulcer; Neovascularization; Red Eye(s); Blurred Vision; Visual Disturbances; Corneal Infiltrates; Excessive Tear Production; Eye Pain
- FOCUS NIGHT & DAYInjury
9681121-2015-00525 · Received Jul 15, 2015
Device type: Lenses, Soft Contact, Extended Wear (LPM)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Inflammation; Scarring; Uveitis; Loss of Vision
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0609-2020 · Started Aug 14, 2018
Reason given: The product may be counterfeit and could have microbial issues.
Cause as FDA categorized it: Counterfeit · Device type: Lenses, Soft Contact, Extended Wear (LPM)
Z-1821-2020 · Started Aug 1, 2018
Reason given: Potentially counterfeit products in/and counterfeit packaging were imported to the U.S.
Cause as FDA categorized it: Counterfeit · Device type: Lenses, Soft Contact, Extended Wear (LPM)
Published research
The most relevant PubMed records for "Focus Night"[tiab]. The summary above synthesizes these.
- Comparatively analysing the postoperative optical performance of different intraocular lenses: a prospective observational study.
Guo S, Huang H, Li B, et al. · BMC Ophthalmol · 2024Observational Study, Comparative Study
- Therapeutic use of Focus Night & Day contact lenses.
Kanpolat A, Uçakhan OO · Cornea · 2003
- Dryness and discomfort with silicone hydrogel contact lenses.
Fonn D, Dumbleton K · Eye Contact Lens · 2003Clinical Trial, Comparative Study
- Efficacy of multipurpose solutions against Acanthamoeba species.
Borazjani RN, Kilvington S · Cont Lens Anterior Eye · 2005Comparative Study
- Therapeutic use of silicone hydrogel contact lenses in children.
Bendoriene J, Vogt U · Eye Contact Lens · 2006
- Do swimming goggles limit microbial contamination of contact lenses?
Wu YT, Tran J, Truong M, et al. · Optom Vis Sci · 2011Comparative Study
- Local oxygen transmissibility of disposable contact lenses.
Bruce A · Cont Lens Anterior Eye · 2003
- Continuous wear contact lens surface chemistry and wearability.
Nicolson PC · Eye Contact Lens · 2003Review
- Quantity and conformation of lysozyme deposited on conventional and silicone hydrogel contact lens materials using an in vitro model.
Suwala M, Glasier MA, Subbaraman LN, et al. · Eye Contact Lens · 2007
- Comparative clinical performance of two silicone hydrogel contact lenses for continuous wear.
Morgan PB, Efron N · Clin Exp Optom · 2002Clinical Trial, Comparative Study
- Therapeutic use of a silicone hydrogel contact lens in selected clinical cases.
Ambroziak AM, Szaflik JP, Szaflik J · Eye Contact Lens · 2004Clinical Trial
- Clinical evaluation of silicone hydrogel lens wear with a new multipurpose disinfection care product.
Zigler L, Cedrone R, Evans D, et al. · Eye Contact Lens · 2007Comparative Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code LPM.
- Bausch and Lomb Polymacon Hydrophilic Contact LensesBausch & Lomb, Inc. · PMA 2002
- methafilcon A Soft (Hydrophilic) Extended Wear Contact LensesCooperVision, Inc. · PMA 2019
- Biofinity (Confilcon A) Soft Contact LensesCooperVision, Inc. · PMA 2012
- Sofmed® breathables XW NEXTCooperVision, Inc. · PMA 2025
- up&up Monthly Performance +CooperVision, Inc. · PMA 2025
- VISTAKON® (etafilcon A) Brand Contact LensesVistakon, Johnson & Johnson Vision Products, Inc. · PMA 2022
- VISTAKON® (senofilcon A) Brand Contact LensesVistakon, Division of Johnson & Johnson Vision Car · PMA 2022
- Ethos AquaTech Monthly XR, Ethos AquaTech Monthly XR for AstigmatismCooperVision, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.